Moxifloxacin-Containing Triple Therapy as Second-Line Treatment for Helicobacter pylori Infection: Effect of Treatment Duration and Antibiotic Resistance on the Eradication Rate-Reference-Cited by-同舟云学术

Moxifloxacin-Containing Triple Therapy as Second-Line Treatment for Helicobacter pylori Infection: Effect of Treatment Duration and Antibiotic Resistance on the Eradication Rate

Published:2009-09-09 Issue:5 Volume:14 Page:429-437
ISSN:1083-4389
Container-title:Helicobacter
language:en
Short-container-title:

Author:

Yoon Hyuk,Kim Nayoung,Lee Byoung Hwan,Hwang Tae Jun,Lee Dong Ho,Park Young Soo,Nam Ryoung Hee,Jung Hyun Chae,Song In Sung

Publisher

Wiley

Subject

Infectious Diseases,Gastroenterology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1523-5378.2009.00709.x/fullpdf

Reference42 articles.

1. Helicobacter pylori infection;Suerbaum;N Engl J Med,2002

2. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report;Malfertheiner;Gut,2007

3. American College of Gastroenterology guideline on the management of Helicobacter pylori infection;Chey;Am J Gastroenterol,2007

4. Distribution of antibiotic MICs for Helicobacter pylori strains over a 16-year period in patients from Seoul, South Korea;Kim;Antimicrob Agents Chemother,2004

5. Institutional difference of antibiotic resistance of Helicobacter pylori strains in Korea;Kim;J Clin Gastroenterol,2006

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rapid diagnosis and precision treatment of Helicobacter pylori infection in clinical settings;Critical Reviews in Microbiology;2024-06-24

2. Study of Zuojin Pill in Treating Chronic Atrophic Gastritis by UPLC-Q-TOF/MS Based on Serum and Urine Metabolomics Combined with Network Pharmacology;International Journal of Analytical Chemistry;2021-03-01

3. Helicobacter pylori Infection and Atrophic Corpus Gastritis on Patients with Intellectual Disability: Challenges in the Clinical Translation of Personalized Medicine;Personalized Medicine, in Relation to Redox State, Diet and Lifestyle;2020-10-14

4. Update on quinolone-containing rescue therapies for Helicobacter pylori infection;World Journal of Gastroenterology;2020-04-21

5. Primary and secondary antibiotic resistance of Helicobacter pylori in Korea from 2003 to 2018;Helicobacter;2019-09-11